Status:
COMPLETED
Interventions to Help More Low-income Smokers Quit
Lead Sponsor:
Washington University School of Medicine
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Tobacco Use Cessation
Smoking Behaviors
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
In a Hybrid Type 2 randomized trial, 1,980 low-income smokers from nine states with high smoking prevalence will be recruited from 2-1-1 helplines to receive either current standard practice (Quitline...
Detailed Description
There is an urgent need to engage more low-income smokers in activities that lead to quitting. The current standard of practice for population-level tobacco treatment is phone-based cessation counseli...
Eligibility Criteria
Inclusion
- Age ≥21
- English-speaking
- Daily smoker
- Does not have a full home smoking ban
- Recruited from those who called 2-1-1 for themselves and are not in acute crisis
Exclusion
- Pregnant women, because recommended tobacco cessation actions differ for this subset of smokers
Key Trial Info
Start Date :
March 31 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 29 2023
Estimated Enrollment :
1973 Patients enrolled
Trial Details
Trial ID
NCT04311983
Start Date
March 31 2020
End Date
September 29 2023
Last Update
October 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110